HAYLEY RUEBUSCH: Open Payments
NPI 1124674403 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 26 payments from 15 companies in 2025. Trend: 2023 $1,021 · 2024 $432 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $183 |
| CSL Behring | 3 | $75 |
| Regeneron Healthcare Solutions, Inc. | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| GENZYME CORPORATION | 1 | $39 |
| Actelion Pharmaceuticals US, Inc. | 1 | $32 |
| PFIZER INC. | 1 | $28 |
| Blueprint Medicines Corporation | 1 | $28 |
| Pharming Healthcare, Inc. | 1 | $27 |
| Amgen Inc. | 1 | $24 |
Products named: AIRSUPRA, Haegarda, DUPIXENT, AYVAKIT, FASENRA, TAKHZYRO, UPTRAVI, PANZYGA.
Industry payments across TN — which companies pay providers there.
